6:45 PM
 | 
Oct 19, 2007
 |  BC Extra  |  Politics & Policy

Aetna issues new ESA policy

Private insurer Aetna issued a new policy regarding its coverage of erythropoiesis-stimulating agents (ESAs) that is less restrictive than that of the Centers for Medicare & Medicaid Services (CMS). For example, Aetna would cover ESA initiation to treat chemotherapy-induced anemia in patients with hemoglobin...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >